The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Phosphatidylcholine breakdown and signal transduction
Exton, J. H. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90186-4 · Cited by 960
Pharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
A G Protein Couples Serotonin and GABA B Receptors to the Same Channels in Hippocampus
Andrade, R., Malenka, R. C., & Nicoll, R. A. (1986) · Science · doi:10.1126/science.2430334 · Cited by 865
Regulation of inositol phospholipid-specific phospholipase C isozymes.
Rhee, S. G., & Choi, K. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42284-3 · Cited by 741
(2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(01)80026-2 · Cited by 677
Agonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Peroutka, S. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03166.x · Cited by 521
The two-state model of receptor activation
Leff, P. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88989-0 · Cited by 488
Self-citationDe Vivo, M., & Maayani, S. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24854-6 · Cited by 424
Self-citationDiversity and Selectivity of Receptor-G Protein Interaction
Gudermann, T., Kalkbrenner, F., & Schultz, G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002241 · Cited by 368
P2-Purinergic Receptors: Subtype-Associated Signaling Responses and Structure
Harden, T. K., Boyer, J. L., & Nicholas, R. A. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002545 · Cited by 324
Fluorescent Labeling of Purified β2 Adrenergic Receptor
Gether, U., Lin, S., & Kobilka, B. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28268 · Cited by 278
The classification of seven transmembrane receptors in recombinant expression systems.
Kenakin, T. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06948-0 · Cited by 270
Robb, S., Cheek, T. R., Hannan, F. L., Hall, L. M., Midgley, J. M., & Evans, P. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06385.x · Cited by 248
Felder, C. C., Kanterman, R. Y., Ma, A. L., & Axelrod, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2187 · Cited by 220
A three-state receptor model of agonist action
Leff, P., Scaramellini, C., Law, C., & McKechnie, K. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01105-x · Cited by 196
Self-citationThe human thyrotropin receptor activates G-proteins gs and Gq/11
Allgeier, A., Offermanns, S., Van Sande, J., Spicher, K., Schultz, G., & Dumont, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36705-4 · Cited by 192
Van Sande, J., Raspé, E., Perret, J., Lejeune, C., Maenhaut, C., Vassart, G., & Dumont, J. E. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90209-q · Cited by 187
Sanders‐Bush, E., Burris, K. D., & Knoth, K. M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22189-9 · Cited by 154
5-Hydroxytryptamine receptors.
Zifa, E., & Fillion, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00462-4 · Cited by 143
Do classical hallucinogens act as 5-HT2 agonists or antagonists?
Glennon, R. A. (1990) · PubMed · Cited by 136
Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
Berg, K. A., Clarke, W. P., Sailstad, C. A., Saltzman, A. G., & Maayani, S. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09724-x · Cited by 134
Self-citationFelder, C. C., Williams, H. L., & Axelrod, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6477 · Cited by 100
Gettys, T. W., Fields, T. A., & Raymond, J. R. (1994) · Biochemistry · doi:10.1021/bi00180a024 · Cited by 94
Zhang, D., & Weinstein, H. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00059a021 · Cited by 85
Shah, B. H., & Milligan, G. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08650-x · Cited by 78
Almaula, N., Ebersole, B. J., Ballesteros, J. A., Weinstein, H., & Sealfon, S. C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09149-7 · Cited by 73
Receptor subtype and density determine the coupling repertoire of the 5-ht2 receptor subfamily
Lucaites, V. L., Nelson, D. L. G., Wainscott, D. B., & Baez, M. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00423-7 · Cited by 72
Berg, K. A., Clarke, W. P., Chen, Y., Ebersole, B. J., McKay, R. D. G., & Maayani, S. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10196-x · Cited by 64
Self-citationGiles, H., Lansdell, S. J., Bolofo, M. L., Wilson, H. L., & Martin, G. R. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16705.x · Cited by 64
The Stability of the Agonist β2-Adrenergic Receptor-Gs Complex: Evidence for Agonist-Specific States
Krumins, A. M., & Barber, R. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.144 · Cited by 64
Quick, M. W., Simon, M. I., Davidson, N., Lester, H. A., & Aragay, A. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43792-1 · Cited by 63
Burris, K. D., Breeding, M., & Sanders‐Bush, E. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20333-0 · Cited by 62
Serotonin 5‐HT2C Receptor Stimulates Cyclic GMP Formation in Choroid Plexus
Kaufman, M. J., Hartig, P. R., & Hoffman, B. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010199.x · Cited by 61
Berg, K. A., Maayani, S., & Clarke, W. P. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09405-2 · Cited by 57
Self-citationMullaney, I., Mitchell, F. M., McCALLUM, J. F., Buckley, N. J., & Milligan, G. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81401-k · Cited by 40
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationG Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Metadata
- Authors
- Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 54
- Issue
- 1
- Pages
- 94-104
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2164339448
- Cited by
- 510
- References
- 38
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.